AGP Picks
View all

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on July 29, 2026

Alvotech announces successful closure of FDA inspection of manufacturing facility
Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
Kalsec Names New Executive Vice President and Chief Commercial Officer
Natural Health Trends Reports Second Quarter 2026 Financial Results
Avocado Green Mattress Expands Retail Presence in Kansas Through Partnership with Furniture Mall
Rose Hill Life Sciences Appoints Bryan Smith as Scientific Advisor
Angelman Syndrome Foundation and Citizen Health Partner to Put Advanced AI to Work for Every Angelman Family
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Victory Marine Holdings’ Dunn & Groux Beverage Holdings Expands GUTSI™ Mineral-First Platform Across Beverages, Supplements and Functional Nutrition
LincNutri Launches Clean-Label 12-in-1 Milk Thistle Formula for Daily Liver Support
Cynet Releases 1H 2026 CyOps ECHO Report: Abused Identities, Gateways, and Trust Take the Place of Exploited Code
SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
Wearable Technology Market Size to Grow from USD 272.80 Billion in 2026 at a 15.85% CAGR
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France
NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative
Clene to Present at The Canaccord 46th Annual Growth Conference
RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.